Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Fractyl Health (GUTS) Change in Receivables (2023 - 2024)

Fractyl Health's Change in Receivables history spans 2 years, with the latest figure at -$7000.0 for Q1 2024.

For the quarter ending Q1 2024, Change in Receivables fell 240.0% year-over-year to -$7000.0, compared with a TTM value of -$41000.0 through Dec 2024, down 286.36%, and an annual FY2024 reading of -$22000.0, down 200.0% over the prior year.
Change in Receivables for Q1 2024 was -$7000.0 at Fractyl Health, down from -$2000.0 in the prior quarter.
The five-year high for Change in Receivables was $51000.0 in Q2 2023, with the low at -$32000.0 in Q3 2023.